The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Despite DEA Accommodation, Many Pharmacies Prohibit Hydrocodone Refills
October 19th 2014Although pharmacies can legally dispense remaining refills of prescriptions for rescheduled hydrocodone combination products submitted prior to October 6, 2014, over the next 6 months, many drug chains have chosen not to honor those refills.
Read More
Predicting Partial Response to PPI Therapy
October 16th 2014As nearly one-third of patients with gastroesophageal reflux disease are partial responders to proton pump inhibitors (PPIs), health care professionals could benefit from reliable methods that predict who will respond to PPIs and who will not.
Read More
Professional Advice for the 2014 Next-Generation Pharmacistâ„¢ Award Winners
October 15th 2014Although Fred Eckel, RPh, MS, says pharmacy is a rewarding profession, he advises the 2014 Next-Generation Pharmacistâ„¢ Award winners to "not get frustrated when things don't get done as quickly as you would like to see them get done."
Watch